BiotechTube
Speid & Associates

Speid & Associates

Toronto, United States· Est.
speedingnewdrugstomarket.org
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2005, Speid & Associates is a US-based, private consulting firm offering high-level regulatory strategy and drug development acceleration services. Led by founder and President Dr. Lorna Speid, the firm leverages decades of industry experience to guide clients through complex global regulatory pathways, boasting a 100% success rate in regulatory appeals. The company operates as an integrated extension of client teams, providing C-suite and investor support to mitigate development risks and expedite the path to market for new therapies across a broad range of therapeutic areas.

OncologyMetabolic DiseasesAnti-infectivesPulmonary DiseasesWomen’s HealthBone DisordersAutoimmune DiseasesRare DiseasesNeglected DiseasesCNS Disorders

Technology Platform

Proprietary methodology and deep expertise in global regulatory strategy and integrated drug development, with specific technical mastery in CMC for injectables and solid dosage forms.

Opportunities

Growing complexity in drug development (e.g., cell/gene therapy) and the rise of virtual biotechs without in-house regulatory teams create strong demand.
Specialization in rare/neglected diseases and regulatory appeals provides a defensible niche.
Increased regulatory emphasis on patient engagement aligns with the founder's charitable work.

Risk Factors

High dependence on the founder's expertise and personal brand (key-person risk).
Competition from large consulting firms and other niche specialists.
Revenue tied to the cyclical biopharma funding environment.
Advisory model carries reputational risk if client programs fail despite consultation.

Competitive Landscape

Competes with large global consulting firms (e.g., McKinsey, Deloitte), specialized life science consultancies (e.g., Parexel, Certara's consulting arm), and numerous independent regulatory affairs consultants. Differentiation is based on deep, hands-on regulatory experience, a specific track record in successful appeals, and integrated CMC/development expertise.

More companies in Digital Health & Biotech SaaS →More companies in United States →